### [Zenke et al. Page 1091][1] Radiotherap. is a mainstay of cancer treatment and improvements in efficacy are long awaited. DNA-dependent protein kinase (DNA-PK) is a key driver of one of the main DNA repair pathways. Zenke and colleagues report a new generation, potent, selective, and orally

中文翻译：

---

本期精选文章

### [Zenke等。[第1091页] [1]放射治疗。癌症是癌症治疗的中流efficacy柱，期待提高疗效。DNA依赖性蛋白激酶（DNA-PK）是一种主要的DNA修复途径的关键驱动力。Zenke和同事报告了新一代的，有效的，选择性的和口服的